… Circulating biomarkers have been recently investigated among patients undergoing
endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). Considering the …

… study, we used this robust immunoassay to investigate the potential role of circulating
proteins with proposed involvement in various processes associated with the pathophysiology of …

… biomarkers, pathogenic mechanisms, or therapeutic targets … sizes, some promising
biomarkers need to be validated in … of the pathogenesis of AAA and promote biomarker discovery …

… dysbiosis might contribute to the pathogenesis and progression of abdominal aortic …
biomarkers and novel therapeutic targets. Specifically, exo-circRNAs can be used as biomarkers of …

… Mice with infrarenal abdominal aortic aneurysm were used to … increased during abdominal
aortic aneurysm progression, … aortic diameter, indicating its potential as a potent biomarker …

… pharmacological treatment against … therapeutic targets and pharmacological strategies
paving the way for the implementation of future clinical studies exploring these novel therapeutic …

… as clinical biomarkers and novel therapeutic targets for AD … pathophysiology and highlight
their potential as biomarkers … the abdominal aorta or the limitation to the ascending aorta. It …

… Furthermore, pharmacological interventions could be developed to reprogram a “diseased”
epigenetic landscape, to be used as a therapeutic target for the treatment of such …

… the pathogenesis of AAA and looking for new biomarkers will … a new molecular therapy
strategy for the treatment of AAA and … of AAA comprise a complex pathophysiological process that …

… (thoracic aorta aneurysm, TAA) and abdominal (abdominal aorta aneurysm, AAA) aorta. …
as drug targets is challenging for AAA treatment, thus the issue needs further investigation. …